Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Weisman

Showing results (61-70 of 468) with videos related to

Pageof 47
Sort By:
The American Journal of Medicine|October 30, 1987
Use of radiographs to measure outcome in rheumatoid arthritisM H Weisman
Arthritis and Rheumatism|July 1, 1980
Clinical photography in the rheumatic diseasesM H Weisman, R Turner
Current Opinion in Rheumatology|March 2, 2016
Infection, malignancy, switching, biosimilars, antibody formation, drug survival and withdrawal, and dose reduction: what have we learned over the last year about tumor necrosis factor inhibitors in rheumatoid arthritis?Irina Ianculescu, Michael H Weisman
The American Journal of Medicine|December 5, 2009
Idiopathic chilblainsShraddha Prakash, Michael H Weisman
Nature Clinical Practice. Rheumatology|August 26, 2006
Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritisWonuk Lee, Michael H Weisman
The Journal of Rheumatology|December 16, 2021
The Need for SPACE to Plan the Future for SpondyloarthritisMark Hwang, Michael H Weisman
Arthritis Care & Research|June 2, 2025
What Are the On-Ramps to Predict Psoriatic Arthritis? Does Monitoring C-Reactive Protein Levels Help?Zheni Stavre, Michael H Weisman
Anesthesiology|April 1, 1972
Hypotension following intraocular acetylcholineK A Rongey, H Weisman
Rheumatic Diseases Clinics of North America|April 29, 2020
Spondyloarthritis: The Changing Landscape-Are We There Yet?Xenofon Baraliakos, Michael H Weisman
The Journal of Rheumatology|July 6, 2006
The predictive power of anti-cyclic citrullinated peptide antibodies: window into understanding gene/ environment/immunity interactionsWonuk Lee, Michael H Weisman
Pageof 47

Showing results (61-70 of 468) with videos related to

Sort By:
Pageof 47
The American Journal of Medicine|October 30, 1987
Use of radiographs to measure outcome in rheumatoid arthritisM H Weisman
Arthritis and Rheumatism|July 1, 1980
Clinical photography in the rheumatic diseasesM H Weisman, R Turner
Current Opinion in Rheumatology|March 2, 2016
Infection, malignancy, switching, biosimilars, antibody formation, drug survival and withdrawal, and dose reduction: what have we learned over the last year about tumor necrosis factor inhibitors in rheumatoid arthritis?Irina Ianculescu, Michael H Weisman
The American Journal of Medicine|December 5, 2009
Idiopathic chilblainsShraddha Prakash, Michael H Weisman
Nature Clinical Practice. Rheumatology|August 26, 2006
Treating axial manifestations in ankylosing spondylitis in the presence of peripheral arthritisWonuk Lee, Michael H Weisman
The Journal of Rheumatology|December 16, 2021
The Need for SPACE to Plan the Future for SpondyloarthritisMark Hwang, Michael H Weisman
Arthritis Care & Research|June 2, 2025
What Are the On-Ramps to Predict Psoriatic Arthritis? Does Monitoring C-Reactive Protein Levels Help?Zheni Stavre, Michael H Weisman
Anesthesiology|April 1, 1972
Hypotension following intraocular acetylcholineK A Rongey, H Weisman
Rheumatic Diseases Clinics of North America|April 29, 2020
Spondyloarthritis: The Changing Landscape-Are We There Yet?Xenofon Baraliakos, Michael H Weisman
The Journal of Rheumatology|July 6, 2006
The predictive power of anti-cyclic citrullinated peptide antibodies: window into understanding gene/ environment/immunity interactionsWonuk Lee, Michael H Weisman
Pageof 47